The Polysaccharide Science

The Molecule

What is a Polysaccharide?

Polysaccharides are long-chain carbohydrate polymers composed of monosaccharide units linked by glycosidic bonds. Unlike proteins or nucleic acids, polysaccharides derive their biological activity not from a linear sequence code, but from three-dimensional conformation, chain length, branching pattern, and — crucially for pharmaceutical applications — the degree and position of chemical modification.

In biological systems, polysaccharides serve structural roles (cellulose, chitin), energy storage functions (glycogen, starch), and — most relevant to our work — surface coating and signalling roles. Glycosaminoglycans (GAGs) are a family of linear polysaccharides that coat the epithelial surfaces of organs and mediate protection, lubrication, and cellular recognition. The bladder urothelium relies entirely on its GAG layer for barrier integrity.

The pharmaceutical application of polysaccharides represents one of the most demanding areas of pharmaceutical chemistry — the synthesis of semi-synthetic analogues that replicate natural GAG function with molecular precision and clinical reliability.

The inner surface of the bladder urothelium is coated by a continuous layer of glycosaminoglycans — predominantly heparan sulphate, chondroitin sulphate, hyaluronic acid, and dermatan sulphate. This GAG layer is not merely a passive barrier; it is an active, dynamic surface that regulates the interaction between urine and the underlying urothelial cells.

In healthy physiology, the GAG layer prevents the adhesion of bacteria, crystals, ions, and proteins to the urothelial surface. It maintains the integrity of the epithelium, regulates water permeability, and modulates local immunological responses. Its absence — even partial disruption — correlates directly with urothelial hypersensitivity, chronic pain, and the characteristic symptom complex of Interstitial Cystitis.

Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) is now understood, in significant part, as a disease of GAG layer dysfunction. Patients demonstrate quantifiably reduced GAG layer density on cytoscopic biopsy, elevated permeability to potassium (the "potassium sensitivity test"), and characteristic urothelial histopathology consistent with chronic irritant exposure.

The logical therapeutic response is GAG layer replenishment — providing the bladder with an exogenous polysaccharide that mimics the natural GAG coating, restores barrier integrity, and allows the urothelium to heal. This is precisely what Pentosan Polysulfate Sodium (PPS) achieves.